找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 ESCI期刊Physics & Imaging in Radiation Oncology 2024/2025影响因子:3.411 (PHYS IMAG RADIAT ONC) (NULL). (ONCOLOGY)(肿瘤学)Emergin  ...234
Total Citations:1349; 2023 JIF:3.411; JIFRank: 110/322 ; Rank-JIF: 110; Number-of-JIF:322; 5 Year JIF:3.474; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.6; Immediacy Index:0.9; Immediacy Index-dealt:0.968; 2023 JCI:0.92; JCI Rank: 88/322 ; Total Articles:114; JCI Quartile:Q2; JCI Percentile:74.26; Eigenfactor:0.002; Normalized Eigenfactor:0.487; Article Influence Score:0.766; JIF Percentile:80.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:115; % of Articles in Citable items:0.9913; Cited Half-Life:2.9; Citing Half-Life:5; % of OA Gold:0.8144; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS,
投票 ESCI期刊Pleura and Peritoneum 2024/2025影响因子:1.445 (PLEURA PERITONEUM) (2364-7671). (ONCOLOGY)(肿瘤学)Emerging Sources Citati  ...234
Total Citations:338; 2023 JIF:1.445; JIFRank: 263/322 ; Rank-JIF: 263; Number-of-JIF:322; 5 Year JIF:2.194; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.2; Immediacy Index:0.3; Immediacy Index-dealt:0.331; 2023 JCI:0.51; JCI Rank: 203/322 ; Total Articles:16; JCI Quartile:Q3; JCI Percentile:38.1; Eigenfactor:0; Normalized Eigenfactor:0.074; Article Influence Score:0.428; JIF Percentile:43.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:20; % of Articles in Citable items:0.8; Cited Half-Life:5.3; Citing Half-Life:6.5; % of OA Gold:0.9531; Publisher name:SCIENDO; Publisher address:BOGUMILA ZUGA 32A, WARSAW, Poland, MAZOVIA, 01-811;
投票 ESCI期刊International Cancer Conference Journal 2024/2025影响因子:0.531 (INT CANCER CONF J) (2192-3183). (ONCOLOGY)(肿瘤学)Emerg  ...234
Total Citations:226; 2023 JIF:0.531; JIFRank: 302/322 ; Rank-JIF: 302; Number-of-JIF:322; 5 Year JIF:0.631; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.5; Immediacy Index:0.1; Immediacy Index-dealt:0.183; 2023 JCI:0.13; JCI Rank: 300/322 ; Total Articles:44; JCI Quartile:Q4; JCI Percentile:6.99; Eigenfactor:0; Normalized Eigenfactor:0.068; Article Influence Score:0.14; JIF Percentile:6.4; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:49; % of Articles in Citable items:0.898; Cited Half-Life:3.8; Citing Half-Life:8.2; % of OA Gold:0.1047; Publisher name:L N GUMILYOV EURASIAN NATL UNIV; Publisher address:PUSHKIN ST, 11, RM 210, ASTANA, K
投票 ESCI期刊Onkourologiya 2024/2025影响因子:0.163 (ONKOUROLOGIYA) (1726-9776). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:62; 2023 JIF:0.163; JIFRank: 318/322 ; Rank-JIF: 318; Number-of-JIF:322; 5 Year JIF:0.182; 5 Year JIF Quartile:Q4; JIF Without Self Cites:<0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.064; 2023 JCI:0.02; JCI Rank: 319/322 ; Total Articles:55; JCI Quartile:Q4; JCI Percentile:1.09; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.013; JIF Percentile:1.4; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:67; % of Articles in Citable items:0.8209; Cited Half-Life:NULL; Citing Half-Life:6; % of OA Gold:0.9471; Publisher name:ASME; Publisher address:TWO PARK AVE, NEW YORK, USA, NY, 10016-5990;
投票 ESCI期刊Case Reports in Oncological Medicine 2024/2025影响因子:0.618 (CASE REP ONCOL MED) (2090-6706). (ONCOLOGY)(肿瘤学)Emergin  ...234
Total Citations:492; 2023 JIF:0.618; JIFRank: 299/322 ; Rank-JIF: 299; Number-of-JIF:322; 5 Year JIF:0.898; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.126; 2023 JCI:0.15; JCI Rank: 298/322 ; Total Articles:8; JCI Quartile:Q4; JCI Percentile:7.61; Eigenfactor:0; Normalized Eigenfactor:0.088; Article Influence Score:0.185; JIF Percentile:7.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:10; % of Articles in Citable items:0.8; Cited Half-Life:7.1; Citing Half-Life:7.6; % of OA Gold:0.9796; Publisher name:KOREAN BIOCHIP SOCIETY-KBCS; Publisher address:KOREA SCI & TECHNOL CENT, #310, 635-4,
投票 ESCI期刊Oncology and Therapy 2024/2025影响因子:3.222 (ONCOL THER) (2366-1070). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:476; 2023 JIF:3.222; JIFRank: 129/322 ; Rank-JIF: 129; Number-of-JIF:322; 5 Year JIF:3.292; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:0.5; Immediacy Index-dealt:0.533; 2023 JCI:0.45; JCI Rank: 225/322 ; Total Articles:19; JCI Quartile:Q3; JCI Percentile:30.28; Eigenfactor:0.001; Normalized Eigenfactor:0.188; Article Influence Score:0.857; JIF Percentile:60.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:26; % of Articles in Citable items:0.7308; Cited Half-Life:2.9; Citing Half-Life:5.1; % of OA Gold:1; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Breast Cancer-Basic and Clinical Research 2024/2025影响因子:1.831 (BREAST CANCER-BASIC) (1178-2234). (ONCOLOGY)(肿瘤学)E  ...234
Total Citations:679; 2023 JIF:1.831; JIFRank: 241/322 ; Rank-JIF: 241; Number-of-JIF:322; 5 Year JIF:2.407; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.2; Immediacy Index-dealt:0.236; 2023 JCI:0.48; JCI Rank: 216/322 ; Total Articles:12; JCI Quartile:Q3; JCI Percentile:33.07; Eigenfactor:0.001; Normalized Eigenfactor:0.123; Article Influence Score:0.563; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:18; % of Articles in Citable items:0.6667; Cited Half-Life:7.1; Citing Half-Life:6.7; % of OA Gold:0.9672; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Eurasian Journal of Medicine and Oncology 2024/2025影响因子:0.831 (EURASIAN J MED ONCOL) (NULL). (ONCOLOGY)(肿瘤学)Emerg  ...234
Total Citations:211; 2023 JIF:0.831; JIFRank: 296/322 ; Rank-JIF: 296; Number-of-JIF:322; 5 Year JIF:0.826; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.1; Immediacy Index-dealt:0.187; 2023 JCI:0.36; JCI Rank: 255/322 ; Total Articles:35; JCI Quartile:Q4; JCI Percentile:20.96; Eigenfactor:0; Normalized Eigenfactor:0.062; Article Influence Score:0.147; JIF Percentile:8.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.7778; Cited Half-Life:3.3; Citing Half-Life:7; % of OA Gold:0.9248; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United State
投票 ESCI期刊International Journal of Surgery-Oncology 2024/2025影响因子:0.359 (INT J SURG-ONCOL) (2471-3864). (ONCOLOGY)(肿瘤学)Emer  ...234
Total Citations:104; 2023 JIF:0.359; JIFRank: 309/322 ; Rank-JIF: 309; Number-of-JIF:322; 5 Year JIF:0.402; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:<0.1; Immediacy Index-dealt:0.031; 2023 JCI:0.04; JCI Rank: 315/322 ; Total Articles:5; JCI Quartile:Q4; JCI Percentile:2.33; Eigenfactor:0; Normalized Eigenfactor:0.02; Article Influence Score:0.166; JIF Percentile:4.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:5; % of Articles in Citable items:1; Cited Half-Life:6.3; Citing Half-Life:5.8; % of OA Gold:0.9286; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Rehabilitation Oncology 2024/2025影响因子:1.166 (REHABIL ONCOL) (2168-3808). (ONCOLOGY)(肿瘤学)Emerging Sources Citation  ...234
Total Citations:222; 2023 JIF:1.166; JIFRank: 287/322 ; Rank-JIF: 287; Number-of-JIF:322; 5 Year JIF:1.187; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.9; Immediacy Index:0.3; Immediacy Index-dealt:0.371; 2023 JCI:0.17; JCI Rank: 294/322 ; Total Articles:10; JCI Quartile:Q4; JCI Percentile:8.85; Eigenfactor:0; Normalized Eigenfactor:0.065; Article Influence Score:0.277; JIF Percentile:11; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:19; % of Articles in Citable items:0.5263; Cited Half-Life:4.9; Citing Half-Life:7.3; % of OA Gold:0.9867; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON
投票 ESCI期刊Hepatic Oncology 2024/2025影响因子:1.241 (HEPAT ONCOL) (2045-0923). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:263; 2023 JIF:1.241; JIFRank: 273/322 ; Rank-JIF: 273; Number-of-JIF:322; 5 Year JIF:3.293; 5 Year JIF Quartile:Q2; JIF Without Self Cites:1.2; Immediacy Index:<0.1; Immediacy Index-dealt:0.077; 2023 JCI:0.53; JCI Rank: 199/322 ; Total Articles:6; JCI Quartile:Q3; JCI Percentile:38.35; Eigenfactor:0; Normalized Eigenfactor:0.049; Article Influence Score:0.744; JIF Percentile:15.4; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:6; % of Articles in Citable items:1; Cited Half-Life:6.7; Citing Half-Life:4.9; % of OA Gold:0.9333; Publisher name:AMER ASSOC ADVANCEMENT SCIENCE; Publisher address:1200 NEW YORK AVE, NW, WASHINGTON, U
投票 ESCI期刊International Journal of Particle Therapy 2024/2025影响因子:2.187 (INT J PART THER) (NULL). (ONCOLOGY)(肿瘤学)Emerging S  ...234
Total Citations:488; 2023 JIF:2.187; JIFRank: 214/322 ; Rank-JIF: 214; Number-of-JIF:322; 5 Year JIF:2.322; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2; Immediacy Index:0.5; Immediacy Index-dealt:0.556; 2023 JCI:0.43; JCI Rank: 231/322 ; Total Articles:20; JCI Quartile:Q3; JCI Percentile:33.58; Eigenfactor:0.001; Normalized Eigenfactor:0.199; Article Influence Score:0.676; JIF Percentile:53.2; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:22; % of Articles in Citable items:0.9091; Cited Half-Life:3.8; Citing Half-Life:6.3; % of OA Gold:0.839; Publisher name:UNIV NIS, FAC SCI MATH; Publisher address:PO BOX 224, VISEGRADSKA 33, NIS, SERB
投票 ESCI期刊Cancer Reports 2024/2025影响因子:1.576 (CANCER REP-US) (NULL). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:1076; 2023 JIF:1.576; JIFRank: 259/322 ; Rank-JIF: 259; Number-of-JIF:322; 5 Year JIF:1.625; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.4; Immediacy Index:0.5; Immediacy Index-dealt:0.557; 2023 JCI:0.31; JCI Rank: 268/322 ; Total Articles:131; JCI Quartile:Q4; JCI Percentile:16.93; Eigenfactor:0.002; Normalized Eigenfactor:0.45; Article Influence Score:0.42; JIF Percentile:19.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:173; % of Articles in Citable items:0.7572; Cited Half-Life:2.6; Citing Half-Life:6.5; % of OA Gold:0.7299; Publisher name:BIBLIOTECA NACL CUBA JOSE MARTI; Publisher address:AVE INDEPENDENCIA & 20 M
投票 ESCI期刊Turk Onkoloji Dergisi-Turkish Journal of Oncology 2024/2025影响因子:0.328 (TURK ONCOL DERG) (1300-7467). (ONCOLOGY)(肿  ...234
Total Citations:115; 2023 JIF:0.328; JIFRank: 309/322 ; Rank-JIF: 309; Number-of-JIF:322; 5 Year JIF:0.263; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:<0.1; Immediacy Index-dealt:0.038; 2023 JCI:0.05; JCI Rank: 314/322 ; Total Articles:58; JCI Quartile:Q4; JCI Percentile:2.64; Eigenfactor:0; Normalized Eigenfactor:0.029; Article Influence Score:0.052; JIF Percentile:4.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:65; % of Articles in Citable items:0.8923; Cited Half-Life:4; Citing Half-Life:9.3; % of OA Gold:0.9479; Publisher name:ELSEVIER SCI LTD; Publisher address:125 London Wall, London, England, EC2Y 5AS;
投票 ESCI期刊Kidney Cancer 2024/2025影响因子:1.184 (KIDNEY CANCER) (2468-4562). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:163; 2023 JIF:1.184; JIFRank: 280/322 ; Rank-JIF: 280; Number-of-JIF:322; 5 Year JIF:1.269; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:1; Immediacy Index-dealt:1.122; 2023 JCI:0.15; JCI Rank: 298/322 ; Total Articles:3; JCI Quartile:Q4; JCI Percentile:9.13; Eigenfactor:0; Normalized Eigenfactor:0.069; Article Influence Score:0.387; JIF Percentile:25.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:12; % of Articles in Citable items:0.25; Cited Half-Life:4.5; Citing Half-Life:5.6; % of OA Gold:0.9796; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Journal of Cancer Prevention 2024/2025影响因子:2.518 (J CANCER PREV) (2288-3649). (ONCOLOGY)(肿瘤学)Emerging Sources Cit  ...234
Total Citations:972; 2023 JIF:2.518; JIFRank: 183/322 ; Rank-JIF: 183; Number-of-JIF:322; 5 Year JIF:3.184; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.1; Immediacy Index-dealt:0.152; 2023 JCI:0.41; JCI Rank: 237/322 ; Total Articles:16; JCI Quartile:Q3; JCI Percentile:26.55; Eigenfactor:0.001; Normalized Eigenfactor:0.167; Article Influence Score:0.662; JIF Percentile:43.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:21; % of Articles in Citable items:0.7619; Cited Half-Life:6.6; Citing Half-Life:7.6; % of OA Gold:0.9873; Publisher name:KEAI PUBLISHING LTD; Publisher address:16 DONGHUANGCHENGGEN NORTH ST, Buildi
投票 ESCI期刊Cardio-Oncology 2024/2025影响因子:3.255 (CARDIO-ONCOLOGY) (NULL). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:497; 2023 JIF:3.255; JIFRank: 129/322 ; Rank-JIF: 129; Number-of-JIF:322; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:3; Immediacy Index:0.8; Immediacy Index-dealt:0.833; 2023 JCI:0.7; JCI Rank: 145/322 ; Total Articles:36; JCI Quartile:Q2; JCI Percentile:55.12; Eigenfactor:0.001; Normalized Eigenfactor:0.396; Article Influence Score:0.557; JIF Percentile:60.1; JIF Quartile:Q2; AIS Quartile:NULL; Citable Items:46; % of Articles in Citable items:0.7826; Cited Half-Life:3.3; Citing Half-Life:6.8; % of OA Gold:1; Publisher name:FIRENZE UNIV PRESS; Publisher address:JOURNALS DIVISION, BORGO ALBIZI, 28, FIRENZ
投票 ESCI期刊Journal of Gastrointestinal Cancer 2024/2025影响因子:1.693 (J GASTROINTEST CANC) (1941-6628). (ONCOLOGY)(肿瘤学)Emerging  ...234
Total Citations:1933; 2023 JIF:1.693; JIFRank: 253/322 ; Rank-JIF: 253; Number-of-JIF:322; 5 Year JIF:1.429; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.6; Immediacy Index:0.3; Immediacy Index-dealt:0.301; 2023 JCI:0.31; JCI Rank: 268/322 ; Total Articles:63; JCI Quartile:Q4; JCI Percentile:16.93; Eigenfactor:0.002; Normalized Eigenfactor:0.533; Article Influence Score:0.319; JIF Percentile:21.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:91; % of Articles in Citable items:0.6923; Cited Half-Life:3.8; Citing Half-Life:6.1; % of OA Gold:0.0961; Publisher name:IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC; Publisher address:445 HOES
投票 ESCI期刊Lung Cancer-Targets and Therapy 2024/2025影响因子:5.163 (LUNG CANCER-TARGETS) (NULL). (ONCOLOGY)(肿瘤学)Emerging Sources  ...234
Total Citations:429; 2023 JIF:5.163; JIFRank: 65/322 ; Rank-JIF: 65; Number-of-JIF:322; 5 Year JIF:3.891; 5 Year JIF Quartile:Q2; JIF Without Self Cites:5.1; Immediacy Index:2; Immediacy Index-dealt:2.155; 2023 JCI:0.6; JCI Rank: 177/322 ; Total Articles:5; JCI Quartile:Q3; JCI Percentile:45.19; Eigenfactor:0; Normalized Eigenfactor:0.102; Article Influence Score:0.926; JIF Percentile:80; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:7; % of Articles in Citable items:0.7143; Cited Half-Life:5.4; Citing Half-Life:4.9; % of OA Gold:0.8889; Publisher name:TURKISH SOC THERMAL SCIENCES TECHNOLOGY; Publisher address:TIBTD MAKINA MUHENDISLIGI BOLU
投票 ESCI期刊Journal of Kidney Cancer and VHL 2024/2025影响因子:1.977 (J KIDNEY CANCER VHL) (2203-5826). (ONCOLOGY)(肿瘤学)Emerging S  ...234
Total Citations:235; 2023 JIF:1.977; JIFRank: 234/322 ; Rank-JIF: 234; Number-of-JIF:322; 5 Year JIF:1.997; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.8; Immediacy Index:0.5; Immediacy Index-dealt:0.519; 2023 JCI:0.32; JCI Rank: 263/322 ; Total Articles:19; JCI Quartile:Q4; JCI Percentile:18.48; Eigenfactor:0; Normalized Eigenfactor:0.053; Article Influence Score:0.456; JIF Percentile:27.5; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:23; % of Articles in Citable items:0.8261; Cited Half-Life:4.2; Citing Half-Life:8.2; % of OA Gold:0.9412; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United St
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 10:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块